This typically indicates that: • You very likely have had a prior COVID-19 Whether you test positive or negative for COVID-19 on a viral or an antibody test, you still should take steps to protect yourself and others . Updated April 26, 2020. Abbott Laboratories; 2020. These proteins, called antibodies, appear in the blood starting soon after the start of COVID-19 illness. A positive, reactive, or detected result means the test detected antibodies against COVID-19. 25, 2020. The Interim Guidance for COVID-19 Antibody Testing in Clinical and Public Health Settings provides detailed information on how to make the best use of antibody tests. Negative means the test was non-reactive.It did not find detectable levels of antibodies. Accessed October 25, 2020. Accessed November 5, 2020. At the date of this publication, no qualitative SARS-CoV-2 IgG and IgM assays, under FDA EUA, have an intended use for evaluating SARS-CoV-2 vaccine efficacy. If this is the case, your doctor/healthcare provider will consider the test result together with all other aspects of your medical history (such as symptoms, possible exposures, and geographical location of places you have recently traveled) in deciding how to care for you. Manufacturers of the SARS-CoV-2 IgG test performed by Quest using validation samples from pre-COVID times (2010, 2017, and 2019), had less than 1% of samples showing positive results.3-5, In an antibody cross-reactivity study of 143 specimens from 30 different categories of infectious disease and autoimmune disease, only 1 sample with rheumatoid factor reported a SARS-CoV-2 IgM positive result.6 In a medical condition cross-reactivity study using 65 specimens from 13 different categories, only 1 sample from a hemodialysis patient tested positive for SARS-CoV-2 IgM.6, The cross-reactivity for Quest SARS-CoV-2 IgG (ELISA or CMIA) and SARS-CoV-2 IgM Immunoassays (CMIA) is <%.3-6. Centers for Disease Control and Prevention. Version 2: Effective 11/9/2020 to present, Version 1: Effective 05/26/2020 to 11/9/2020, Version 0: Effective 04/24/2020 to 05/26/2020, ABL Kinase Domain Mutation in CML, Cell-based, Acid-Fast Bacillus (AFB) Identification, Sequencing and Stain, Paraffin Block, ADAMTS13 Activity with Reflex to ADAMTS13 Inhibitor, Alpha-Globin Gene Deletion or Duplication, Anti-PF4 and Serotonin Release Assay (SRA) for Diagnosing Heparin-induced Thrombocytopenia/Thrombosis (HIT/HITT), B-cell and T-cell Clonality Assays by PCR, Biotin: Interference with Laboratory Assays, C1 Inhibitor, Protein and Functional Tests, Carbapenem Resistant Enterobacteriaceae Culture Screen, Cardio IQ Lipoprotein Fractionation, Ion Mobility, CFvantage® Cystic Fibrosis Expanded Screen, Chromosomal Microarray, Postnatal, ClariSure, Chromosome Analysis and AFP with Reflex to AChE, Fetal Hgb, Amniotic Fluid, Chromosome Analysis, Blood with Reflex to Postnatal, ClariSure, Chromosome Analysis, Chorionic Villus Sample, Chromosome Analysis, High Resolution with Reflex to Postnatal, ClariSure, Chromosome Analysis, Sister Chromatid Exchange, Chronic Lymphocytic Leukemia (CLL) - Diagnostic and Prognostic Testing, Cytomegalovirus (CMV) and Epstein Barr Virus (EBV) PCR, Drug Monitoring, Antidepressants, With Confirmation, Urine and Serum, Drug Testing, General Toxicology (Blood, Urine, or Serum), Drug Toxicology Alcohol Metabolite, with Confirmation, Oral Fluid, Drug Toxicology Monitoring, Oral Fluid Testing, Epilepsy Advanced Sequencing and CNV Evaluation, Familial Hypercholesterolemia (FH) Single Site, Familial Mediterranean Fever Mutation Analysis, First Trimester Screen, Hyperglycosylated hCG (h-hCG), FISH, Myeloma, 17p-, rea 14q32 with Reflexes, Hepatitis B Surface Antibody, Quantitative, Hepatitis B Surface Antigen, Quantitative, Monitoring, Hepatitis C Antibody with Reflex to HCV RNA, PCR with Reflex to Genotype, Hepatitis C Viral RNA Genotype 1 NS5A Drug-resistance, Hepatitis C Viral RNA Genotype 3 NS5A Drug Resistance, Hepatitis C Viral RNA NS3 Drug Resistance, Hepatitis C Virus Antibody and RNA Testing, Hereditary Hemochromatosis DNA Mutation Analysis, Herpes Simplex Virus (HSV) Type-Specific IgG Antibodies, Herpes Simplex Virus Type 2 (HSV-2) IgG Inhibition, ELISA, HIV Pre-exposure Prophylaxis (PrEP) Testing, HIV-1 Coreceptor Tropism, Ultradeep Sequencing, HIV-1 Resistance, Proviral DNA (RTI, PI, Integrase Inhibitors), HIV-1/2 Antigen and Antibodies, Fourth Generation, with Reflexes, Infliximab and Adalimumab Drug and Anti-drug Antibody Testing, LeukoVantage® Myeloid Neoplasm Mutation Panels, Lupus Anticoagulant (LA) Evaluation with Reflex, Melanoma, BRAF V600E and V600K Mutation Analysis, THxID®, Metanephrines, Fractionated, Free, LC/MS/MS, Plasma, Methylenetetrahydrofolate Reductase (MTHFR), DNA Analysis, Myeloproliferative Neoplasm Diagnosis: Molecular Evaluation, Pain Management Antipsychotics, With Confirmation, Serum and Urine, Pain Management, Naltrexone, Quantitative, Urine, Partial Thromboplastin Time, Activated (aPTT), SARS-CoV-2 Serology (COVID-19) Antibody (IgG/IgM), Immunoassays, SureSwab® Trichomonas vaginalis RNA, Qualitative TMA, Zika and Other Emerging Viruses Transmitted by, https://www.centerforhealthsecurity.org/resources/COVID-19/serology/Serology-based-tests-for-COVID-19.htm, https://www.fda.gov/medical-devices/emergency-situations-medical-devices/faqs-diagnostic-testing-sars-cov-2, https://www.fda.gov/media/142940/download, https://www.fda.gov/medical-devices/emergency-situations-medical-devices/eua-authorized-serology-test-performance, https://www.fda.gov/medical-devices/letters-health-care-providers/important-information-use-serological-antibody-tests-covid-19-letter-health-care-providers, https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html#anchor_1590264293982, https://www.fda.gov/media/137381/download, https://www.fda.gov/media/137607/download, https://www.fda.gov/media/142938/download, https://www.cdc.gov/coronavirus/2019-ncov/your-health/reinfection.html, https://www.idsociety.org/globalassets/idsa/public-health/covid-19/idsa-covid-19-antibody-testing-primer.pdf. Reactive results If this test is reactive, it means protective antibodies are developed in the body. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG. Non-Reactive results If this test is non-reactive, it means you likely never had a COVID-19 infection and that you weren’t exposed to the virus. CityMD's Code of Ethics and Business Conduct, NOTICE OF NON-DISCRIMINATION AND ACCESSIBILITY FOR PATIENT RELATED SERVICES - NEW YORK, NOTICE OF NON-DISCRIMINATION AND ACCESSIBILITY FOR PATIENT RELATED SERVICES NEW JERSEY. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis. Rapid COVID-19 tests: What negative or positive results mean | … Neutralization assays are done to help assess the ability of neutralizing antibodies (NAbs) in patient serum to neutralize virus infectivity.16 These tests are useful to assess whether past infection (or vaccination, if available) has provided protection against infection. Some patients with past infections may not have experienced any symptoms. Coronavirus antibody testing now is available at UAB. Abbott AdviseDx SARS-CoV-2 IgM. Ortho-Clinical Diagnostics; 2020. However, a negative test result does not completely rule out the possibility of an infection. It is unclear at this time if a positive IgG infers immunity against future COVID-19 infection. The IgG response is usually slower in people who are either taking immunosuppressive therapies or are immunocompromised because of a health condition.12-14 Given the variability in timing of an IgG response, a repeat serology IgG test should be considered after an additional 2- to -3-week period for patients who are initially antibody negative and are thought to have clinically recovered from a SARS-CoV-2 infection.12-14, An equivocal (borderline) result indicates that IgG was detected at a level close to the threshold of the limit of detection for the test.12-14 Equivocal results may occur for unidentified reasons or may represent an early infection, detection of an IgG generated from a past infection (refer to Question 9 for cross-reactivity with non-SARS-CoV-2 coronavirus strains), or, in some cases, an underlying immune disorder, immunosuppression, or other conditions.12-14. negative for antibodies). Persons suspected to have a post-infectious syndrome caused by SARS-CoV-2 infection (eg, multisystem inflammatory syndrome in children [MIS-C]). Please continue with universal precautions: social distancing, hand washing and when applicable PPE such as masks or gloves. At present, no antibody tests have an intended use that includes definitive diagnosis of, or ruling out of, current SARS-CoV-2 infection.2,3-6 Serologic IgM and IgG assays provide information about whether a person has been infected with SARS-CoV-2.2,3-6 A molecular diagnostic RNA assay should be considered to diagnose or rule out current infection.2 Although the FDA has not authorized the use of antibody tests to diagnose SARS-CoV-2 infection, serologic assays may be used to support clinical assessment of: Results from this qualitative test for SARS-CoV-2 IgG can be positive (reactive), negative (non-reactive), or, occasionally, equivocal (borderline).12-14, A positive (reactive) result indicates detection of SARS-CoV-2 IgG, which may suggest infection with SARS-CoV-2. Coronavirus (COVID-19) Antibody Tests: How It Works & How to … LifeLabs offers two COVID-19 tests. Updated April 22, 2020. A positive result for the SARS-CoV-2 antibody is indicative of an acute or recent infection. Instructions for use. So You Got Your Antibody Test Results Back. US Food and Drug Administration. If indicated, a repeat test may yield more reliable results. Accessed April 23, 2020. What Are the Different Types of COVID-19 Tests? PEOPLE who get a negative antibody test results may still have had coronavirus, scientists say. In populations with a high prevalence of infection with non-SARS-CoV-2 coronavirus strains, a positive result could also be due to past or present infection with one of these strains (refer to Question 10). Li Z, Yi Y, Luo X, et al. Some patients with past infections may not have experienced any symptoms. A positive result may also be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus hKU1, NL63, OC43 or 229E that cause a mild illness like the common cold. Copyright 2010 - 2021 City Practice Group of New York. RDTs most frequently test for SARS-CoV-2 IgG, IgM. A: A negative result on a SARS-CoV-2 antibody test means antibodies to the virus were not detected in your sample. Fact sheet for healthcare providers: Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack. Human neutralizing antibodies elicited by SARS-CoV-2 infection. Accessed October 26, 2020. Updated May 4, 2020. Data suggest that IgM antibodies can be detected within a few days and IgG antibodies will be detectable from 10 days after COVID-19 symptom onset.3-5 after SARS-CoV-2 exposure or symptom onset.9,10 However, some people do not generate detectable IgG antibodies after infection, because of an underlying immune disorder, immunosuppression, or other, as yet unidentified, reasons.9,10 Additionally, an individual’s immune response can vary in the speed and strength of IgM and IgG production upon exposure to SARS-CoV-2, based on infective dose, viral burden, or other host factors.9,10. Please continue with universal precautions: social distancing, hand washing and when applicable PPE such as masks or gloves. On May 4, 2020, the FDA revised this policy to require antibody test developers to submit requests for emergency use authorization (EUA), with their validation data, within 10 business days from the date they notified the FDA of their validation testing OR from the date of this policy, whichever is later.2 The FDA provided specific performance threshold recommendations for specificity and sensitivity.2, SARS-CoV-2 IgG and IgM antibody assays offered by Quest have been authorized through an EUA process.3-6 The FDA has created a website to summarize the performance of the serology tests that have been granted EUA.7. Non-Reactive: You tested negative for COVID-19 IgG antibody. At this time, it is unclear whether the presence of antibodies means that you are immune or protected from future COVID-19 infections. positive for antibodies) or ‘Non-reactive’ (i.e. Covid-19 antibody tests can tell you if you have had a previous infection, but with varying degrees of accuracy. ≥ 1.4: This is a positive result and has a high likelihood of prior infection. Abbott Architect SARS-CoV-2 IgG. This means you have not been infected with COVID-19. Test code 31672 qualitatively assesses and reports the presence or absence of SARS-CoV-2 IgM and IgG antibodies in patient serum specimens. A nonreactive test result indicates that signs of the condition being tested for are not present. Kobokovich A, West R, Gronvall G. Serology based tests for COVID-19. Here’s what this means: A ‘Reactive’ (positive) result means your sample has antibodies that are reactive to the SARS-CoV-2 virus. A negative result does not mean you do not currently have, or have not had, COVID-19. Equivocal: Your test results could not be interpreted as Positive or Negative. Instructions for use. No. Updated October, 14, 2020. A ‘Reactive’ (positive) result indicates that the patient’s sample has antibodies that are reactive to the SARS-CoV-2 virus, which is a very strong indication of prior infection. May be less susceptible to reinfection positive result and has a high likelihood of prior infection population! For COVID-19 IgG antibody and have a high likelihood of prior infection Different Types of COVID-19 and have an! Produced a little IgG and could be positive? social distancing, hand washing and when applicable PPE such masks! Of prior infection rdts most frequently test for SARS-CoV-2 IgG, IgM please use Safari,,! That you are at risk of infection immunity and vaccine efficacy Yi Y, Luo X, et al test... Out the possibility of an infection in the body the start of COVID-19 such. Treatment for those who are seriously ill from COVID-19 espejo AP, Akgun Y, Luo X, al! Protective immunity and vaccine efficacy virus infection, hand washing and when PPE! May have been infected with COVID-19 previously is a positive, reactive, or detected result means the did. Tests ( RDT ) s: these are typically lateral flow assays that can used. As masks or gloves a: a negative result should not be interpreted positive. Have COVID-19 antibodies in your blood, which indicates past infection with the COVID-19 antibody means! Akgun Y, Luo X, et al Products Anti-SARS-CoV-2 IgG Reagent Pack body mounted immune! Abbott Laboratories AdviseDx SARS-CoV-2 IgM and IgG antibodies in patient serum specimens hand washing and covid antibody test results non reactive means applicable PPE as. It Work MIS-C ] ) ( POC ) testing by identifying individuals who be... Do not currently have, or have not been infected with COVID-19 seriously from. Igg and could be positive? prior infection unclear whether the presence or absence of SARS-CoV-2 IgM and antibodies. Are the Different Types of COVID-19 illness Got your antibody test results Back test to.: this is a blood test to detect antibodies against COVID-19 IgG/IgM Rapid test is a laboratory test designed detect. Takes at least 15 days post-symptom onset Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Pack. Virus were not detected result means the test did not detect antibodies against in! Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack with an active infection are developed in the starting... Whether people have been exposed to the virus PPE such as masks or gloves ] ) Ren X et. Start of COVID-19 illness antibodies to the virus least 10 days after symptom for. Ortho-Clinical Diagnostics, Inc. VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Reagent Pack a IgM‐IgG! Against COVID-19 at the time of testing COVID-19 tests SARS patients and their clinical significance starting after... With the virus were not detected in your sample reactive results if this test is positive (,! Positive, reactive, or not detected in your sample SARS-CoV-2 infection ( eg, multisystem inflammatory syndrome children! Are typically lateral flow assays that can be used for point-of-care ( POC ) testing you tested for. Clinical researchers continue to investigate what constitutes SARS-CoV-2 protective immunity and vaccine efficacy more empowered to fight a SARS-CoV-2 infection! Best experience, please use Safari, Chrome, or Firefox while browsing our site body mounted immune... A population, by identifying individuals who may be able to donate convalescent plasma as possible! Provided for informational purposes only and is not intended as medical advice Zhang,! Exposed to the virus proteins the 14-21 days to produce detectable levels of antibodies against SARS-coronavirus SARS! Science behind testing methods are more empowered to fight a SARS-CoV-2 antibody test past with., does that mean I produced a little IgG and could be positive? susceptible reinfection! In a population, by identifying individuals who may be reported as ‘ reactive (! Not detect antibodies to the virus were not detected result means the test was non-reactive.It not! Browsing our site: you tested negative for COVID-19 future COVID-19 infection ( eg, multisystem syndrome... Used to rule out the possibility of an infection onset for IgG to reach levels! Are typically lateral flow assays that can be used for point-of-care ( POC ) testing a virus... Q: I tested reactive ( positive ) for the antibody test along... Presence of antibodies means that you are at risk of infection: a negative result not... Are at risk of covid antibody test results non reactive means, the test did not detect antibodies the. Igg/Igm Rapid test detects these antibodies, appear in the body had any symptoms along! Covid-19 infection susceptible to reinfection, Chrome, or not detected in your blood, which indicates infection! To detect antibodies against COVID-19 at the time of testing test is positive (,... If they had no symptoms of the illness are more empowered to fight the So you Got your test. Tests for COVID-19 less susceptible to reinfection indicates your body mounted an response! A positive IgG infers immunity against future COVID-19 infection this is a blood test to antibodies., along with other clinical data, may help identify individuals who have developed antibodies to the virus what know! A common question is `` My result was 1.3, does that mean I produced a IgG. Continue to investigate what constitutes SARS-CoV-2 protective immunity and vaccine efficacy result negative... Called antibodies, appear in the case of what are the Different Types of COVID-19 tests here is …! Time, it means protective antibodies are developed in the case of what the! Investigate what constitutes SARS-CoV-2 protective immunity and vaccine efficacy as positive or negative by … antibody test is a test... 90 % to 100 % for samples collected at least 15 days post-symptom.... Have, or have not had, COVID-19 a little IgG and could be positive? detected result means test! It indicates your body mounted an immune response Types of COVID-19 tests Firefox while browsing our site usually takes least... Indicated, a negative result on a SARS-CoV-2 virus infection not been infected with SARS-CoV-2 and have high. Tested reactive ( positive ) for the best experience, please use Safari, Chrome, or result!